Search the site.

Types of Neuroendocrine Tumours

Neuroendocrine Tumours (NETs) is an umbrella name for a number of different types of tumours, which can arise in different areas of the body. It can be…

Patient Guide

This booklet has been developed to provide information about neuroendocrine tumours (NETs) for patients and their families.

Early signals from alpha-emitter PRRT in SSTR2-positive NETs

A first-in-human trial of [212Pb]VMT-α-NET, a targeted alpha-particle therapy for SSTR2-positive NETs, has reported early activity at ASCO GI 2026.

Grades of Neuroendocrine (NET) Cancers

What G1, G2 and G3 mean for a neuroendocrine cancer diagnosis – plain-language explanation of grade, Ki-67, and how they shape treatment options.

Understanding Neuroendocrine

Neuroendocrine tumours (NETs) is the umbrella term for a group of unusual, often slow-growing cancers.

A second PRRT in the FDA pipeline: 177Lu-edotreotide decision due August 2026

The FDA is expected to decide on ITM-11 (177Lu-edotreotide) for GEP-NETs by 28 August 2026, based on the Phase 3 COMPETE trial results.

Types of scans for NET Cancers

There are various types of scans that may or may not be suitable for your type of NETs. Here is a summary of some scans you might encounter.

In-Service Training

Custom training for nurses – we'll work with you to design a session tailored to your team's NETs care needs.